{"input_url":"https://www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","gnews_decode":"https://www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","http_status":202,"final_url":"https://www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","html_length":2418,"trafilatura_result":"None","verdict":"EXTRACTION_FAILED","metadata_title":"JavaScript is disabled","metadata_author":null}